Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study
F. Sangalli, L. Moiola, S. Bucello, P. Annovazzi, A. Rizzo, M. Radaelli, G. Vitello, L. M. E. Grimaldi, A. Ghezzi, V. Martinelli, G. ComiVolume:
31
Language:
english
Pages:
4
DOI:
10.1007/s10072-010-0344-z
Date:
January, 2011
File:
PDF, 238 KB
english, 2011